Norris Medicines Limited (NORRIS) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE744C01029
Key metrics
- Market Cap
- ₹16 Cr
- P/E Ratio
- —
- EPS
- —
- Book Value
- —
- P/B Ratio
- —
- ROE
- —
- ROCE
- —
- Debt / Equity
- —
- Net Margin
- —
- Revenue Growth
- —
- Profit Growth
- —
- Dividend Yield
- —
- 52W High
- ₹19.63
- 52W Low
- ₹12.00
- Market Cap Band
- micro cap
- Face Value
- —
About Norris Medicines Limited
Norris Medicines Limited manufactures and sells pharmaceutical formulations in India. The company offers nonsterile dosage products, such as tablets, capsules, liquid orals, and copical ointments, as well as injections and medicinal formulations. Its products include antibiotics, anti-inflammatory/pain management, antiemetic, nutrition, gastro, cough/cold, skin and allergy, antimalarial, diabetic, cardiac, dental, and other medicine products. The company also provides contract and loan license manufacturing services for pharma companies. It exports its products. Norris Medicines Limited was incorporated in 1990 and is based in Ankleshwar, India.
- Headquarters
- Ankleshwar, India
- Promoter Holding
- 76%
The full Norris Medicines Limited analysis
Create a free account to open the complete NORRIS deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.